Science Explorer Back to mapMap
Discussion
Topic · Pulmonary and Respiratory Medicine

Sarcoma Diagnosis and Treatment

Sarcoma Diagnosis and Treatment is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 61k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on research and treatment related to various types of sarcomas, including osteosarcoma, soft tissue sarcoma, Ewing's sarcoma, rhabdomyosarcoma, and synovial sarcoma. It covers topics such as chemotherapy, prognostic factors, genomic characterization, and the development of clinical practice guidelines for diagnosis and treatment. The papers also discuss the use of immunohistochemical markers for diagnostic purposes.

  • Osteosarcoma
  • Soft Tissue Sarcoma
  • Ewing's Sarcoma
  • Rhabdomyosarcoma
  • Synovial Sarcoma
  • Chemotherapy
  • Prognostic Factors
  • Genomic Characterization
  • Clinical Practice Guidelines
  • Immunohistochemical Marker
Research works
61k
fractional, since 1950
In the world top 10%
6.1k
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+9%
the tick is no change
Largest producer
United States
32% of the 10 largest, 2022-now
Sarcoma Diagnosis and Treatment

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Sarcoma Diagnosis and Treatment research?

By volume, the United States and China publish the most (2.6k and 1.7k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.6k works
  2. 2 China 1.7k works
  3. 3 India 1.1k works
  4. 4 Japan 682 works
  5. 5 Italy 455 works
  6. 6 Germany 400 works
  7. 7 United Kingdom 365 works
  8. 8 France 310 works
  9. 9 Türkiye 271 works
  10. 10 Spain 268 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.0%China: 20.7%India: 13.2%Japan: 8.4%6 others listed: 25.6%32%largest
United States2,587 · 32.0%China1,673 · 20.7%India1,069 · 13.2%Japan682 · 8.4%6 others listed2,069 · 25.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Sarcoma Diagnosis and Treatment research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Sarcoma Diagnosis and Treatment research, followed by Harvard University and Peking University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 143 works
  2. 2 Harvard UniversityUnited States 123 works
  3. 3 Peking UniversityChina 97 works
  4. 4 The University of Texas MD Anderson Cancer CenterUnited States 89 works
  5. 5 Mayo ClinicUnited States 87 works
  6. 6 Memorial Sloan Kettering Cancer CenterUnited States 84 works
  7. 7 Sichuan UniversityChina 79 works
  8. 8 The Ohio State UniversityUnited States 64 works
  9. 9 Shanghai Jiao Tong UniversityChina 64 works
  10. 10 Sun Yat-sen UniversityChina 61 works

Who are the leading researchers in Sarcoma Diagnosis and Treatment?

The most-cited researchers publishing on Sarcoma Diagnosis and Treatment include Ahmedin Jemal, Eric S. Lander and Stacey L. Gabriel.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Eric S. Lander United States 524k citations
  3. 3 Stacey L. Gabriel United States 402k citations
  4. 4 Bert Vogelstein United States 373k citations
  5. 5 Gad A. Getz United States 364k citations
  6. 6 Elaine R. Mardis United States 346k citations
  7. 7 Jun Wang China 340k citations
  8. 8 John P. A. Ioannidis United States 317k citations
  9. 9 Trevor Hastie United States 301k citations
  10. 10 Richard A. Gibbs United States 292k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Sarcoma Diagnosis and Treatment?

The most cited paper in Sarcoma Diagnosis and Treatment is "International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes" (Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al., 1997), with 4,480 citations. Next come "Case report 3" (4,090) and "A System for the Surgical Staging of Musculoskeletal Sarcoma" (2,513).

Most cited papers
#PaperReleasedCitations
1 International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood Open access 15 Mar 1997 4,480
2 Case report 3 Murray K. Dalinka, R. E. Brennan, Arthur S. Patchefsky · Skeletal Radiology 1976 4,090
3 A System for the Surgical Staging of Musculoskeletal Sarcoma William F. Enneking, Suzanne S. Spanier, MARK A. GOODMAN · Clinical Orthopaedics and Related Research Nov 1980 2,513
4 Hypoxia in cancer: significance and impact on clinical outcome Peter W. Vaupel, Arnulf Mayer · Cancer and Metastasis Reviews Review 18 Apr 2007 2,256
5 A System for the Functional Evaluation of Reconstructive Procedures After Surgical Treatment of Tumors of the Musculoskeletal System WILLIAM F. ENNEKING, WILLIAM DUNHAM, Mark C. Gebhardt et al. · Clinical Orthopaedics and Related Research 1993 2,226
All 100 most cited papers, with filters and sorting

Where is Sarcoma Diagnosis and Treatment research done?

The largest centres of Sarcoma Diagnosis and Treatment research in 2022-now are Beijing (China), New York (United States), Shanghai (China) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Rishikesh, Villejuif and Oujda.

Largest cities, 2022-now

  1. 1 BeijingChina 238 works
  2. 2 New YorkUnited States 159 works
  3. 3 ShanghaiChina 153 works
  4. 4 New DelhiIndia 143 works
  5. 5 LondonUnited Kingdom 129 works
  6. 6 TokyoJapan 128 works
  7. 7 HoustonUnited States 123 works
  8. 8 BostonUnited States 107 works
  9. 9 GuangzhouChina 107 works
  10. 10 ChengduChina 106 works

Where it is the local speciality

  1. RishikeshIN · 20.5 works16×
  2. VillejuifFR · 21.0 works15×
  3. OujdaMA · 24.0 works13×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Sarcoma Diagnosis and Treatment than the world average.

See Sarcoma Diagnosis and Treatment on the map

Where is the best place to study Sarcoma Diagnosis and Treatment?

Among universities, judged by research, Harvard University, University of Toronto and Heidelberg University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 21.45%fractional works in this field (log) →share of work in the world top 10% →Leiden UniversityHeidelberg UniversityHarvard UniversityUniversity of Toronto
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 76.720.6%4.0×123 -1.8%
2University of TorontoCanada 66.519.9%2.8×56 +10.1%
3Heidelberg UniversityGermany 65.722.4%6.0×44 +5.6%
4Leiden UniversityNetherlands 65.027.0%4.2×22 -16.3%
5The Ohio State UniversityUnited States 63.416.8%5.4×64 +46.7%
6University of MiamiUnited States 61.216.7%7.5×45 +23.7%
7Università Cattolica del Sacro CuoreItaly 59.727.3%5.3×22 +67.6%
8Sichuan UniversityChina 59.015.7%3.6×79 +62.5%
9Institute of Cancer ResearchUnited Kingdom 58.929.3%34.8×11 -17.8%
10Stanford UniversityUnited States 58.418.8%2.6×37 +4.7%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Sarcoma Diagnosis and Treatment, country by country

Is Sarcoma Diagnosis and Treatment research growing?

Output in 2022-2025 was 9% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Sarcoma Diagnosis and Treatment.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Sarcoma Diagnosis and Treatment as a percentage of every work published that year, 0.048% in 2024.

still counting0.050%0.10%Sarcoma Diagnosis and Treatment0.044% in 202519801990200020102020

Fractional works of Sarcoma Diagnosis and Treatment over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Sarcoma Diagnosis and Treatment10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Sarcoma Diagnosis and Treatment. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.